Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

457 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells.
Friesen C, Herr I, Krammer PH, Debatin KM. Friesen C, et al. Among authors: krammer ph. Nat Med. 1996 May;2(5):574-7. doi: 10.1038/nm0596-574. Nat Med. 1996. PMID: 8616718
Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death.
Fritzsching B, Oberle N, Pauly E, Geffers R, Buer J, Poschl J, Krammer P, Linderkamp O, Suri-Payer E. Fritzsching B, et al. Blood. 2006 Nov 15;108(10):3371-8. doi: 10.1182/blood-2006-02-005660. Epub 2006 Jul 25. Blood. 2006. PMID: 16868256
Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma.
Ramp U, Dejosez M, Mahotka C, Czarnotta B, Kalinski T, Wenzel M, Lorenz I, Müller M, Krammer P, Gabbert HE, Gerharz CD. Ramp U, et al. Br J Cancer. 2000 Jun;82(11):1851-9. doi: 10.1054/bjoc.2000.1155. Br J Cancer. 2000. PMID: 10839301 Free PMC article.
Suppression of apoptosis in COLO 205 cells by the phorbol ester TPA may be mediated by the PKC isoenzyme alpha.
Weiss E, Vonreyher U, Kittstein W, Moller P, Krammer P, Marks F, Gschwendt M. Weiss E, et al. Int J Oncol. 1997 Jun;10(6):1119-23. doi: 10.3892/ijo.10.6.1119. Int J Oncol. 1997. PMID: 21533493
Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals.
Fritzsching B, Korporal M, Haas J, Krammer PH, Suri-Payer E, Wildemann B. Fritzsching B, et al. Among authors: krammer ph. J Neurol Sci. 2006 Dec 21;251(1-2):91-7. doi: 10.1016/j.jns.2006.09.006. Epub 2006 Nov 7. J Neurol Sci. 2006. PMID: 17092518
Life and Death Decisions in the CD95 System: Main Pro-and Anti-Apoptotic Modulators.
Lavrik IN, Krammer PH. Lavrik IN, et al. Among authors: krammer ph. Acta Naturae. 2009 Apr;1(1):80-3. Acta Naturae. 2009. PMID: 22649588 Free PMC article.
Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas.
Giaisi M, Köhler R, Fulda S, Krammer PH, Li-Weber M. Giaisi M, et al. Among authors: krammer ph. Int J Cancer. 2012 Aug 15;131(4):1003-8. doi: 10.1002/ijc.26458. Epub 2011 Nov 8. Int J Cancer. 2012. PMID: 21952919
Combinatorial treatment of CD95L and gemcitabine in pancreatic cancer cells induces apoptotic and RIP1-mediated necroptotic cell death network.
Pietkiewicz S, Eils R, Krammer PH, Giese N, Lavrik IN. Pietkiewicz S, et al. Among authors: krammer ph. Exp Cell Res. 2015 Nov 15;339(1):1-9. doi: 10.1016/j.yexcr.2015.10.005. Epub 2015 Oct 8. Exp Cell Res. 2015. PMID: 26453936
Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.
Natoli A, Lüpertz R, Merz C, Müller WW, Köhler R, Krammer PH, Li-Weber M. Natoli A, et al. Among authors: krammer ph. Int J Cancer. 2013 Oct 15;133(8):1945-54. doi: 10.1002/ijc.28189. Epub 2013 Apr 25. Int J Cancer. 2013. PMID: 23553437
The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2.
Polier G, Neumann J, Thuaud F, Ribeiro N, Gelhaus C, Schmidt H, Giaisi M, Köhler R, Müller WW, Proksch P, Leippe M, Janssen O, Désaubry L, Krammer PH, Li-Weber M. Polier G, et al. Among authors: krammer ph. Chem Biol. 2012 Sep 21;19(9):1093-104. doi: 10.1016/j.chembiol.2012.07.012. Chem Biol. 2012. PMID: 22999878
457 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page